Preliminary Experience with Intra-Arterial Nicardipine as a Treatment for Cerebral Vasospasm

References

1. ↵
   Macdonald RL, Weir B. Epidemiology. In: Cerebral Vasospasm. San Diego, Ca: Academic Press;2004 :16–18
2. ↵
   Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochirur 1984;70:65–69
3. ↵
   Barnwell SL, Higashida RT, Halbach VV, Dowd CF, Wilson CB, Hieshima GB. Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: reversal of neurological deficits after delayed treatment. Neurosurgery 1989;24:424–429

   CrossRefPubMed
4. Bejjani GK, Bank WO, Olan WJ, Sekhar L. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998;42:979–986

   PubMedWeb of Science
5. Eskridge JM, Newell DW, Pendleton GA. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1990;1:387–399

   PubMed
6. ↵
   Polin R, Coenen V, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284–290

   PubMedWeb of Science
7. ↵
   The American Society of Interventional and Therapeutic Neuroradiology: Mechanical and pharmacologic treatment of vasospasm. AJNR Am J Neuroradiol 2001;22:S26–S27

   FREE Full Text
8. Brothers MF, Hedlund LW, Friedman AH. Arterial rupture during distal vasospasm angioplasty [abstract] Neuroradiology 1997;33:S155
9. Linskey ME, Horton JA, Rao GR, Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. J Neurosurg 1991;74:985–990

   PubMedWeb of Science
10. ↵
    Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661–1668

    Abstract
11. ↵
    Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1998;89:93–100

    PubMedWeb of Science
12. ↵
    Kaku Y, Yonekawa Y, Tetsuya T, Kiyoshi K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77:842–827

    PubMedWeb of Science
13. Kassell NF, Helm G, Simmons N, Philips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:842–847
14. Kazan S. Effects of intra-arterial papaverine on the chronic period of cerebral arterial vasospasm in rats. Acta Neurol Scand 1998;98:354–359

    PubMed
15. ↵
    Milburn JM, Moran CJ, Cross DT, Diringer MN, Pilgram TK, Dacey RG. Increase in diameters of vasospastic intracranial arteries by intraarterial papverine administration. J Neurosurg 1998;88:38–42

    PubMed
16. ↵
    Vajkoczy P, Horn P, Bauhuf C, et al Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001;32:498–505

    Abstract/FREE Full Text
17. ↵
    Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T. Complications associated with intraarterial administration of papaverine for vasospasm following subarachnoid hemorrhage–two case reports. Neurol Med Chir 2000;40:112–115
18. Numaguchi Y, Zoarski GH, Clouston JE, et al. Okawara SH. Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 1997;39:751–759

    CrossRefPubMed
19. ↵
    Mathis JM, Jensen ME, Dion JE. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 1997;39:90–98

    CrossRefPubMed
20. ↵
    Giordano MJ, Pryor JC, Moran CJ, Cross DT, Diringer MN. Intraarterial papaverine may significantly increase intracranial pressure. Chicago: Congress of Neurologic Surgeons;1994
21. ↵
    Cross DT III, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr. Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 1998;19:1319–23

    Abstract
22. ↵
    Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol 2001;56:159–163

    CrossRefPubMed
23. ↵
    Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid hemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochirurgica Suppl (Wein) 1988;42:81–84
24. ↵
    Cardene Product Information. Physicians Desk Reference. Montvale, NJ: Thompson PDR;2000
25. ↵
    Abe K, Iwanaga H, Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesthes 1994;6:99–105
26. Alabad JA, Salom JB, Torregrosa G, Miranda FJ, Jover T, Alborch E. Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 1993;33:707–715

    PubMedWeb of Science
27. Frazee J, Bevan JA, Bevan RD, Jones KR, Bivens LV. Early treatment with diltiazem reduces delayed cerebral vascular narrowing after subarachnoid hemorrhage. Neurosurgery 1988;23:611–615

    PubMed
28. ↵
    Takayasu M, Suzuki Y, Shibuya M, et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 1986;65:80–85

    PubMedWeb of Science
29. ↵
    Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636–642
30. ↵
    Porchet F, Chiolero R, de Tribolet N. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica 1995;137:62–69

    CrossRefPubMed
31. Devlin JW, Coplin WM, Murry KR, Rengachary SS, Wilson RF. Nimodipine-induced acute hypoxemia: case report. Neurosurgery 2000;47:1243–1246, discussion 1246–1247

    PubMed
32. ↵
    Fahy BG. Pseudoobstruction of the colon: early recognition and therapy. J Neurosurg Anesthesiol 1996;8:133–136

    PubMed
33. ↵
    Flamm ES, Adams HP Jr, Beck DW, et al. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988;68:393–400

    PubMedWeb of Science
34. ↵
    Haley EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP, et al. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:537–547

    PubMedWeb of Science
35. Haley EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP, et al. A randomized nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results: a report of the Cooperative Aneurysm Study. J Neurosurg 1993;78:548–553

    PubMedWeb of Science
36. ↵
    Haley EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP, et al. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study. J Neurosurg 1994;80:788–796

    PubMed
37. ↵
    Kasuya H, Onsa H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged release implants for preventing vasospasm in humans. Stroke 2002;33:1011–1015

    Abstract/FREE Full Text